Using semiquantitative RT–PCR and essentially confirming our earlier observations, 76% of NSCLC patients examined showed a two-fold or greater over-representation of S100A2 transcripts in their tumour sample compared to matched normal lung. This evidence concerns the gene S100A2 and neoplasm.